WTF_800X800.jpg

Talking to Everyone Everywhere about HealthCARE Innovation

WTF Health gives you a glimpse of the future of health by introducing you to the people who are going to change it. Jessica DaMassa, the emerging ‘It girl’ of health tech interviewing, chats it up with the ‘who’s who’ of the health innovation set.

wintertech 2017 ballroom 2.jpg

wtF is this about?

 

100’s of Interviews

Health tech’s ‘Who’s who’

 ON THE FUTURE OF HEALTH

 

Meet the health tech startups, VC investors, innovators, and accelerators pushing bleeding edge tech and disruptive solutions into healthcare …and the insurance companies, pharmas, and hospital systems working to shepherd these new ideas into the ‘establishment’ in effort to fix it.

 

From digital health, telehealth, big data and beyond…to payment model innovation, shifting health policy, and investor sentiment, Jessica helps you spot the trends and figure out what’s next…or, ‘What’s The Future?’ Health. (Yes. That’s really what the acronym means.😉)

THE iNTERVIEWS

Subscribe to the WTF Health channel on YouTube to hear the latest about health innovation.


Signify Health’s CEO Kyle Armbrester stops by on IPO day! Hours after ringing the bell on $SGFY’s launch on the New York Stock Exchange, we dig into the health tech company’s $7.1B valuation and plans to help providers, payers, and self-insured employers scale-up their value-based care offerings.

As if one consumer digital health company with an $18.5B exit wasn’t enough, Livongo founder Glen Tullman has decided to give the transformation of healthcare another go – this time as Executive Chairman & CEO of Transcarent. WTF Health’s Jess DaMassa and The Health Care Blog’s Matthew Holt sit down with Glen to hear about the “new kind of experience” that Transcarent is offering self-insured employers and their employees.

Virtual-first primary care company Firefly Health is becoming a health plan! Backed by a $40M Series B, CEO Fay Rotenberg and Executive Chairman Jonathan Bush stop by to explain how they’re providing “half-price healthcare that’s twice as good.” (Or, as only Jonathan can put it: “we’re a bloat-less Kaiser.”)

One Drop just landed a $98.7M deal with Bayer -- and we got the details from CEO Jeff Dachis. The timing of this deal is nothing short of impeccable: less than a year after the life sciences giant led One Drop’s Series B with a $40M investment, and amidst a veritable funding frenzy aimed at growing digital health companies focused on chronic condition management.

On the eve of the finalization of their SPAC IPO and New York Stock Exchange debut as $HIMS, Hims & Hers CEO, Andrew Dudum, sat down with Jess DaMassa to talk about his wellness company's transition into full-on healthcare provider.

“Telehealth has a much bigger role to play than just carrying out transactions,” says Amwell’s President & CEO, Roy Schoenberg, who joins Jess DaMassa for a sweeping philosophical discussion about how telehealth’s role will continue to evolve through the covid19 pandemic and the changes its forced on the healthcare market.

The two big questions healthcare market watchers have for Teladoc Health are: 1) how’s that double integration going? and 2) just how much pushback are you getting from health system clients that look at this “hospital-to-home” virtual care pathway as a little too close to their own business models? We hear from InTouch Health’s former CEO, now Teladoc Health’s President of Hospital and Health Systems, Joe DeVivo and Livongo’s former Chief Medical Officer, Dr. Bimal Shah, who’s now Teladoc Health’s Chief Medical Officer for Product and Analytics.

he thinking behind the merger-of-equals between on-demand mental health company, Ginger, and mindfulness and meditation company, Headspace, is revealed in this in-depth chat with Headspace CEO CeCe Morken and Ginger CEO Russell Glass. The combined entity will be known as Headspace Health, and we're chatting with both of them about go-to-market, strategic direction, and whether or not the next stop is an IPO.

Hinge Health kicked off 2021 with a massive $300M Series D, driving the digital health musculoskeletal care company to a $3B valuation that, normally, would have sent health tech pundits into full-on IPO rumor mode...except that Hinge Health’s co-founder & CEO Daniel Perez beat them to it!

 

WATCH mORE Interviews

(100’s to see!)